|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 871.90 INR | -0.34% |
|
+0.96% | +21.08% |
| May. 08 | Innova Captab Limited, Q4 2026 Earnings Call, May 08, 2026 | |
| May. 07 | Innova Captab March-quarter consol profit 380.8 million rupees | RE |
| Capitalization | 49.89B 522M 447M 409M 387M 717M 722M 4.88B 1.89B 23.71B 1.96B 1.92B 82.52B | P/E ratio 2026 |
28x | P/E ratio 2027 * | 26.3x |
|---|---|---|---|---|---|
| Enterprise value | 49.89B 522M 447M 409M 387M 717M 722M 4.88B 1.89B 23.71B 1.96B 1.92B 82.52B | EV / Sales 2026 |
2.42x | EV / Sales 2027 * | 2.52x |
| Free-Float |
27.81% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Innova Captab Limited
| 1 day | -0.34% | ||
| 1 week | +0.96% | ||
| Current month | +15.94% | ||
| 1 month | +25.58% | ||
| 3 months | +28.44% | ||
| 6 months | +16.05% | ||
| Current year | +21.08% |
| 1 week | 833.05 | 918 | |
| 1 month | 702.3 | 918 | |
| Current year | 622 | 918 | |
| 1 year | 622 | 1,020.7 | |
| 3 years | 421.35 | 1,260 | |
| 5 years | 421.35 | 1,260 | |
| 10 years | 421.35 | 1,260 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2022-03-17 | |
Lokesh Bhasin
DFI | Director of Finance/CFO | - | 2024-03-29 |
Sujit Kumar Dana
CTO | Chief Tech/Sci/R&D Officer | - | 2021-02-11 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 2022-03-17 | |
| Chairman | 54 | 2022-03-17 | |
| Director/Board Member | - | 2020-02-27 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.34% | +0.96% | -5.86% | - | 523M | ||
| -0.89% | +3.26% | +40.69% | +131.73% | 906B | ||
| +0.16% | +3.73% | +57.69% | +43.55% | 555B | ||
| +1.09% | +3.98% | +18.78% | +43.23% | 368B | ||
| -0.94% | -0.94% | +23.89% | +10.73% | 326B | ||
| -0.19% | +3.20% | +37.10% | +14.40% | 289B | ||
| +0.78% | +3.09% | +30.74% | +26.23% | 285B | ||
| -0.04% | +0.99% | +54.36% | -3.18% | 280B | ||
| +0.91% | +1.25% | -30.88% | -49.10% | 208B | ||
| -0.07% | +2.17% | +28.20% | +44.34% | 182B | ||
| Average | +0.23% | +1.92% | +25.47% | +29.10% | 339.9B | |
| Weighted average by Cap. | +0.40% | +2.37% | +34.41% | +50.46% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 15.88B 166M 142M 130M 123M 228M 230M 1.55B 603M 7.54B 623M 610M 26.26B | 19.82B 207M 178M 162M 154M 285M 287M 1.94B 753M 9.42B 778M 761M 32.79B |
| Net income | 1.39B 14.58M 12.49M 11.42M 10.81M 20.02M 20.18M 136M 52.94M 662M 54.71M 53.55M 2.31B | 1.9B 19.85M 17M 15.55M 14.72M 27.25M 27.47M 186M 72.06M 902M 74.48M 72.89M 3.14B |
| Net Debt | - | - |
Employees
1,600
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-14 | 871.90 ₹ | -0.34% | 26,394 |
| 26-05-13 | 874.90 ₹ | +0.35% | 113,985 |
| 26-05-12 | 871.85 ₹ | +1.94% | 70,573 |
| 26-05-11 | 855.25 ₹ | -2.34% | 59,910 |
| 26-05-08 | 875.75 ₹ | +1.40% | 155,822 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
2
Last Close Price
871.90INR
Average target price
971.50INR
Spread / Average Target
+11.42%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- INNOVACAP Stock
Select your edition
All financial news and data tailored to specific country editions

















